person · Reporting owner

Antunes Humberto Calheiros

Disclosed activity across 1 company

Tapewire entity: 41098
SEC CIK: 0001800145

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
LIFECORE BIOMEDICAL, INC. \DE\LFCR · Entity 6447	Director	June 04, 2026	June 05, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LIFECORE BIOMEDICAL, INC. \DE\

Report date June 04, 2026 · Filed June 05, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	72,967	Reported balance After 2026-06-04 transaction · row 1 1 source row Row 1 · 2026-06-04 · Grant · Acquired 25,907 · Balance 72,967 F1: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

Filing footnotes · ownership attribution and instrument terms

F1: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 04, 2026 Filed Jun 5, 2026 20:45 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447	GrantCommon Stock	25,907	Not disclosed	Not disclosed	Disclosure SEC source: 0001800145-26-000002 · wk-form4_1780692316.xml · nonDerivative · entry 1 Antunes Humberto Calheiros · CIK 0001800145 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,967 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026). Read SEC document
July 15, 2025 Filed Jul 17, 2025 20:40 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447	GrantCommon Stock	19,506	Not disclosed	Not disclosed	Disclosure SEC source: 0001005286-25-000089 · wk-form4_1752784823.xml · nonDerivative · entry 1 Antunes Humberto Calheiros · CIK 0001800145 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,060 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof). Read SEC document
August 19, 2024 Filed Aug 21, 2024 23:55 UTC	LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447	GrantCommon Stock	24,554	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-24-038091 · wk-form4_1724284516.xml · nonDerivative · entry 1 Antunes Humberto Calheiros · CIK 0001800145 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,554 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Vests on earlier of July 8, 2025 or the date of the annual meeting of stockholders of the Company first held in calendar year 2025 (provided such date is no less than 50 weeks from July 8, 2024). Read SEC document
August 19, 2024 Filed Sep 16, 2024 19:24 UTC Amendment	LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447	GrantCommon Stock	24,554	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-24-040456 · wk-form4a_1726514653.xml · nonDerivative · entry 1 Antunes Humberto Calheiros · CIK 0001800145 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,554 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Vests on earlier of July 8, 2025 or the date of the annual meeting of stockholders of the Company first held in calendar year 2025 (provided such date is no less than 50 weeks from July 8, 2024). F3 · balance_after: Amendment includes 3,000 shares that were inadvertently omitted from the Form 3 filed on behalf of the reporting person on August 21, 2024. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.